According to the research report titled ‘Global Clinical Trials Support Services Market Size study, by Phase (Phase I, Phase II, Phase III, Phase IV), by Service Type (Clinical Trial Site Management, Patient Recruitment Management, Assay Development, Contract Manufacturing, Other Service Types), and Regional Forecasts 2021-2027’, available with Market Study Report, global clinical trials support services market is expected to register 8.5 % CAGR over 2021-2027.
 

Rising incidence of tropical and infectious diseases, mounting demand for innovative medications from emerging nations, and ever-increasing number of CROs (contract research organizations) are catalyzing the growth of global clinical trials support services market.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/4006483/
 

Additionally, significant investments in R&D by pharmaceutical and biopharmaceutical sectors, low labor costs, and lower prices for product handling are also augmenting the development of the industry vertical.
 

On the contrary, strict regulations for patient enrollment, coupled with high costs of drug development are likely to hinder the growth of the industry space over the ensuing years.
 

Speaking of phase type, worldwide clinical trials support services industry sphere is fragmented into phase IV, phase III, phase II, and phase I. With respect to service type, the marketplace is classified into clinical trial site management, assay development, patient recruitment management, contract manufacturing, and others.
 

As per expert verbatim, Latin America, North America, Europe, and Asia Pacific are significant contributors to industry remuneration. Among these, North America currently holds a major market share, owing to increasing number of registered clinical trial facilities in the region.
 

Parallelly, Europe industry is poised to register a considerable growth rate over the projected period, creditable to substantial presence of pharmaceutical giants in the region.
 

Leading companies in global clinical trials support services market include Eurofins Scientific SE , Parexel International Corporation, Laboratory Corporation of America Holdings, Insight Genetics, Inc.., WuXi AppTec, Alcura Health, Charles River Laboratories International, Inc., IQVIA Holdings, Inc., Icon plc, and Pharmaceutical Product Development (PPD), Inc. among others.
 

Collaborations and mergers among major players suggest that these companies are entering into emerging fields to enable clients to minimize overall time spent on clinical trials, hence reducing the total costs incurred, and allowing for early commercialization of products.